Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome

被引:5
作者
Meyer, C
Talbot, M
Teede, H
机构
[1] Monash Univ, Dept Vasc Sci & Med, Dandenong Hosp, Dandenong, Vic 3175, Australia
[2] Mercy Hosp Women, Melbourne Assisted Concep Ctr, Melbourne, Vic, Australia
关键词
glucose; homeostasis model assessment; Implanon; insulin resistance; Polycystic Ovary Syndrome;
D O I
10.1111/j.1479-828X.2005.00372.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The majority of women with polycystic ovary syndrome (PCOS) have insulin resistance (IR) and have a high risk of developing diabetes. In this retrospective study of women with PCOS, Implanon use was associated with increased insulin resistance, as evidenced by a deterioration in the homeostasis model assessment (HOMA) assessment of insulin resistance, and increased fasting insulin levels. Implanon might increase the risk of diabetes and potentially cardiovascular disease in this already high-risk group. Further research is required to establish the ideal contraceptive preparation in PCOS.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 19 条
  • [1] Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization
    Birdsall, MA
    Farquhar, CM
    White, HD
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) : 32 - 35
  • [2] Implanon® contraceptive implants:: effects on carbohydrate metabolism
    Biswas, A
    Viegas, OAC
    Bennink, HJTC
    Korver, T
    Ratnam, SS
    [J]. CONTRACEPTION, 2001, 63 (03) : 137 - 141
  • [3] Fasting blood glucose: An underestimated risk factor for cardiovascular death - Results from a 22-year follow-up of healthy nondiabetic men
    Bjornholt, JV
    Erikssen, G
    Aaser, E
    Sandvik, L
    Nitter-Hauge, S
    Jervell, J
    Erikssen, J
    Thaulow, E
    [J]. DIABETES CARE, 1999, 22 (01) : 45 - 49
  • [4] Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
    Bonora, E
    Saggiani, F
    Targher, G
    Zenere, MB
    Alberiche, M
    Monauni, T
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2000, 23 (01) : 57 - 63
  • [5] Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome
    Christian, RC
    Dumesic, DA
    Behrenbeck, T
    Oberg, AL
    Sheedy, PF
    Fitzpatrick, LA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2562 - 2568
  • [6] POLYCYSTIC-OVARY-SYNDROME AND RISK FOR MYOCARDIAL-INFARCTION - EVALUATED FROM A RISK FACTOR MODEL BASED ON A PROSPECTIVE POPULATION STUDY OF WOMEN
    DAHLGREN, E
    JANSON, PO
    JOHANSSON, S
    LAPIDUS, L
    ODEN, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (08) : 599 - 604
  • [7] Metabolic effects of implantable steroid contraceptives for women
    Dorflinger, LJ
    [J]. CONTRACEPTION, 2002, 65 (01) : 47 - 62
  • [8] Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
    Guzick, DS
    Talbott, EO
    SuttonTyrrell, K
    Herzog, HC
    Kuller, LH
    Wolfson, SK
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) : 1224 - 1229
  • [9] Homburg R, 1996, HUM REPROD, V11, P29
  • [10] Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk
    Kahn, HS
    Curtis, KM
    Marchbanks, PA
    [J]. DIABETES CARE, 2003, 26 (01) : 216 - 225